STERIS plc (NYSE:STE) Shares Sold by ArrowMark Colorado Holdings LLC

ArrowMark Colorado Holdings LLC trimmed its position in STERIS plc (NYSE:STE - Free Report) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 658,707 shares of the medical equipment provider's stock after selling 3,626 shares during the quarter. STERIS accounts for 1.8% of ArrowMark Colorado Holdings LLC's holdings, making the stock its 8th biggest holding. ArrowMark Colorado Holdings LLC owned 0.67% of STERIS worth $135,404,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new stake in shares of STERIS in the 4th quarter valued at approximately $238,836,000. Raymond James Financial Inc. bought a new stake in shares of STERIS during the fourth quarter worth $223,987,000. Franklin Resources Inc. lifted its stake in shares of STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after acquiring an additional 529,308 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of STERIS by 4,534.6% during the 4th quarter. Wellington Management Group LLP now owns 219,032 shares of the medical equipment provider's stock valued at $45,024,000 after acquiring an additional 214,306 shares in the last quarter. Finally, Boston Trust Walden Corp grew its position in STERIS by 400.4% during the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider's stock worth $46,198,000 after acquiring an additional 179,829 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Analyst Ratings Changes

STE has been the topic of a number of recent research reports. JMP Securities reissued a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research note on Thursday, April 10th. Stephens reissued an "overweight" rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Finally, Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $258.75.

STERIS Trading Down 0.9 %

Shares of NYSE:STE traded down $2.07 during trading on Tuesday, reaching $222.23. The stock had a trading volume of 1,171,245 shares, compared to its average volume of 541,429. STERIS plc has a 52 week low of $200.98 and a 52 week high of $248.24. The firm's fifty day moving average is $223.14 and its 200 day moving average is $218.76. The stock has a market cap of $21.83 billion, a price-to-earnings ratio of 47.18 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.